Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Discover key red flags that indicate budgeting methods aren’t working. This brief overview helps you identify issues and start improving your approach.
10,013 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Citi boosts its Broadcom price target to $500 on expectations of solid AI-driven revenue in the upcoming April quarte...
As AI chips grab headlines, investors wonder if will cerebras soar after its IPO. While history offers clues, the pat...
NVIDIA breached a $5.5 trillion market cap, marking a historic leap for a chipmaker tied to AI. The move highlights t...
As negotiators in Beijing steer talks between the U.S. and China, investors are eyeing three names likely to move: NV...
The S&P 500 reached a new record as Bitcoin faced renewed selling pressure. Analysts say the divide underscores a liq...
Analysts tout gains for an overlooked tech name, but the upside may be clouded by rising costs, competition, and macr...
Gold is climbing as central banks snapping gold drives a new bid, with ETF buyers joining sovereign demand. This piec...
Kraken will migrate all kBTC to Chainlink CCIP, making CCIP the exclusive cross-chain layer for Kraken Wrapped Assets...
XRP faces two major resistance levels that could trigger its next bullish wave. Traders monitor price action after a ...
A large Ukrainian drone strike on Moscow killed several and wounded dozens, intensifying market jitters and fueling a...
Palantir shares moved higher as market chatter tied the AI and national security agenda to politics. Investors weigh ...